Elizabeth Ahern

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan et al. · Immunity · 2020 · 178 citations · Full text

Life Sciences, Immunology, Oncology +16

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma

Ailin Lepletier, Jason Madore, Jake S. O’Donnell et al. · Clinical Cancer Research · 2020 · 112 citations · Full text

Medicine, Immunology, Oncology +17

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis

Arabella Young, Shin Foong Ngiow, Jason Madore et al. · Cancer Research · 2017 · 98 citations

Medicine, Cancer Biology, Oncology +17